| Fady Fawzy Shafeek, MD | |
|
703 Main St, Paterson, NJ 07503-2621 | |
| (973) 754-2000 | |
| Not Available |
| Full Name | Fady Fawzy Shafeek |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 703 Main St, Paterson, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285297986 | NPI | - | NPPES |
| 0906263 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA11348500 (New Jersey) | Primary |
| Entity Name | Medical Associates Of Englewood Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952681918 PECOS PAC ID: 1355512252 Enrollment ID: O20110927000020 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) provided an improvement in overall survival (OS) when added to the standard 1st-line FOLFIRI chemotherapy regimen for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors in the CRYSTAL study.
Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) and the MR Cancer Group at the Norwegian University of Science and Technology (NTNU).
A 'rule book' to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments will be created as part of a collaboration between Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb, announced today (Friday).
The Mayo Clinic is proposing more than $5 billion in investments in and around Rochester as part of an ambitious expansion plan to create what the clinic calls a "Destination Medical Center." Included in that plan is a request for more than $500 million in state taxpayer money to help fund infrastructure as the Mayo grows. Mayo claims the plan would create between 35,000 and 45,000 new jobs. Mayo is already Minnesota's largest private employer with 32,000 employees in the state.
UK scientists have found a naturally occurring molecule in the body which may have important consequences for treating osteoarthritis. Researchers from The University of Manchester and the University of Westminster have found that the molecule, known as Urocortin, protects cells in the joints from being destroyed.
› Verified 9 days ago
| Entity Name | St Josephs Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205425519 PECOS PAC ID: 8628470325 Enrollment ID: O20210716000520 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) provided an improvement in overall survival (OS) when added to the standard 1st-line FOLFIRI chemotherapy regimen for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors in the CRYSTAL study.
Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) and the MR Cancer Group at the Norwegian University of Science and Technology (NTNU).
A 'rule book' to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments will be created as part of a collaboration between Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb, announced today (Friday).
The Mayo Clinic is proposing more than $5 billion in investments in and around Rochester as part of an ambitious expansion plan to create what the clinic calls a "Destination Medical Center." Included in that plan is a request for more than $500 million in state taxpayer money to help fund infrastructure as the Mayo grows. Mayo claims the plan would create between 35,000 and 45,000 new jobs. Mayo is already Minnesota's largest private employer with 32,000 employees in the state.
UK scientists have found a naturally occurring molecule in the body which may have important consequences for treating osteoarthritis. Researchers from The University of Manchester and the University of Westminster have found that the molecule, known as Urocortin, protects cells in the joints from being destroyed.
› Verified 9 days ago
| Entity Name | Passaic Hospitalist Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144903733 PECOS PAC ID: 8426404484 Enrollment ID: O20231026002969 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) provided an improvement in overall survival (OS) when added to the standard 1st-line FOLFIRI chemotherapy regimen for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors in the CRYSTAL study.
Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) and the MR Cancer Group at the Norwegian University of Science and Technology (NTNU).
A 'rule book' to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments will be created as part of a collaboration between Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb, announced today (Friday).
The Mayo Clinic is proposing more than $5 billion in investments in and around Rochester as part of an ambitious expansion plan to create what the clinic calls a "Destination Medical Center." Included in that plan is a request for more than $500 million in state taxpayer money to help fund infrastructure as the Mayo grows. Mayo claims the plan would create between 35,000 and 45,000 new jobs. Mayo is already Minnesota's largest private employer with 32,000 employees in the state.
UK scientists have found a naturally occurring molecule in the body which may have important consequences for treating osteoarthritis. Researchers from The University of Manchester and the University of Westminster have found that the molecule, known as Urocortin, protects cells in the joints from being destroyed.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fady Fawzy Shafeek, MD 703 Main St, Paterson, NJ 07503-2621 Ph: (973) 754-2000 | Fady Fawzy Shafeek, MD 703 Main St, Paterson, NJ 07503-2621 Ph: (973) 754-2000 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) provided an improvement in overall survival (OS) when added to the standard 1st-line FOLFIRI chemotherapy regimen for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors in the CRYSTAL study.
Identifying biomarkers could lead to earlier detection of preeclampsia, which in turn can lead to healthier mothers and children, according to a collaborative study from the Centre of Molecular Inflammation Research (CEMIR) and the MR Cancer Group at the Norwegian University of Science and Technology (NTNU).
A 'rule book' to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments will be created as part of a collaboration between Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb, announced today (Friday).
The Mayo Clinic is proposing more than $5 billion in investments in and around Rochester as part of an ambitious expansion plan to create what the clinic calls a "Destination Medical Center." Included in that plan is a request for more than $500 million in state taxpayer money to help fund infrastructure as the Mayo grows. Mayo claims the plan would create between 35,000 and 45,000 new jobs. Mayo is already Minnesota's largest private employer with 32,000 employees in the state.
UK scientists have found a naturally occurring molecule in the body which may have important consequences for treating osteoarthritis. Researchers from The University of Manchester and the University of Westminster have found that the molecule, known as Urocortin, protects cells in the joints from being destroyed.
› Verified 9 days ago
David Paul Bleeker, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 21 Market St, Paterson, NJ 07501 Phone: 973-754-4200 Fax: 973-754-4201 | |
Walid Baddoura, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, St. Joseph's Regional Medical Center, Paterson, NJ 07503 Phone: 973-754-2270 | |
Dr. Adil Farooki, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 680 Broadway, Paterson, NJ 07514 Phone: 973-754-0999 | |
Dr. Dinesh H Shah, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 21st Ave, Paterson, NJ 07501 Phone: 973-345-1044 Fax: 973-345-3943 | |
Dr. Yana Cavanagh, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, St. Joseph's Regional Medical Center, Internal Medicine, Paterson, NJ 07503 Phone: 973-754-2431 Fax: 973-754-3376 | |
Ruhin Yuridullah, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 802-318-7994 | |
Dr. Haris Kalatoudis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 Main Street, Medicine Department, Paterson, NJ 07503 Phone: 973-754-2000 |